Diagnostic and Therapeutic Challenges of Homozygous and Severe Heterozygous Familial Hypercholesterolemia from Clinical Aspect-A Single-Center Study.

Bíborka Nádró, Judit Kaluha, Hajnalka Lőrincz, Éva Varga, István Balogh, Mariann Harangi

Abstract read

In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bíborka NádróDivision of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

Judit KaluhaDivision of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

Hajnalka LőrinczDivision of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0009-0000-5303-3082

Éva VargaDepartment of Internal Medicine and Hematology, Semmelweis University, 1083 Budapest, Hungary.

István BaloghDepartment of Medical Genetics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0003-3397-2829

Mariann HarangiDivision of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0001-9761-9595

Funding

Hungarian Academy of Sciences Fellowship by the Hungarian Academy of Sciences to support researchers raising childrenMinistry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund TKP2021-EGA-18National Research, Development and Innovation Office K142273

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

familial hypercholesterolemiagenetic testingheterozygoushomozygouslipid-lowering therapieslow-density lipoprotein cholesterolpersonalized medicinetherapy resistance

Identifiers

PMID41303093

DOI10.3390/jcm14228058

PMCPMC12653393

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.